Emberger Syndrome with Concomitant GATA2, NPM1 and FLT3-ITD Mutations in Remission after Allogeneic Stem Cell Transplant

被引：0
|
作者：
Saste, Abhijit Balkrishna [1 ]
Jiang, Feng [2 ]
Arias-Stella, Javier, III [3 ]
Gamalski, Steven [2 ]
Peres, Edward [4 ]
Janakiraman, Nalini [4 ]
Farhan, Shatha [4 ]
机构：
[1] Henry Ford Hlth Syst, Hematol Oncol Bone Marrow Transplant, Detroit, MI USA
[2] Henry Ford Hlth Syst, Hematol Oncol, Detroit, MI USA
[3] Henry Ford Hlth Syst, Dept Pathol & Lab Med, Detroit, MI USA
[4] Henry Ford Hosp, Hematol Oncol & Bone Marrow Transplantat, Detroit, MI 48202 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2015.11.603
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
287
引用
收藏
页码：S208 / S209
页数：2
相关论文
共 50 条
  • [21] Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
    Salah, Mona
    Zawam, Hamdy
    Fouad, Neven Bahaa
    Soliman, Nohair
    Maksoud, Fatma Abdel Wahab Abdel
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2021, 22 (01)
  • [22] Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
    N I Noguera
    E Ammatuna
    D Zangrilli
    S Lavorgna
    M Divona
    F Buccisano
    S Amadori
    C Mecucci
    B Falini
    F Lo-Coco
    Leukemia, 2005, 19 : 1479 - 1482
  • [23] FLT3-ITD, NPM1 MUTATIONS AND WT1 HYPEREXPRESSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    Such, E.
    Cervera, J.
    Valencia, A.
    Fuster, O.
    Senent, M. L.
    Luna, I.
    Marco, E.
    Mallo, M.
    Sole, F.
    Barragan, E.
    Collado, R.
    Vicente, A.
    Amigo, V.
    Hernandez-Boluda, J. C.
    Luno, E.
    Oltra, S.
    Bolufer, P.
    Sanz, M. A.
    Sanz, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 230 - 230
  • [24] Dynamics of Molecular Response in AML Patients with NPM1 and FLT3 Mutations Undergoing Allogeneic Stem Cell Transplant
    Salem, Rana
    Massoud, Radwan
    Mahfouz, Rami
    Bazarbachi, Ali
    El Cheikh, Jean
    BLOOD, 2016, 128 (22)
  • [25] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    R Salem
    R Massoud
    B Haffar
    R Mahfouz
    A Bazarbachi
    J El-Cheikh
    Bone Marrow Transplantation, 2017, 52 : 1187 - 1190
  • [26] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    SalemRana, R.
    Massoud, R.
    Mahfouz, R.
    Bazarbachi, A.
    El-Cheikh, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S341 - S342
  • [27] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    Salem, R.
    Massoud, R.
    Haffar, B.
    Mahfouz, R.
    Bazarbachi, A.
    El-Cheikh, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 (08) : 1187 - 1190
  • [28] FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in Acute Myeloid Leukemia Patients with FLT3-ITD after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Propensity Score- Matching Study
    Zhou, Cuiyan
    Zheng, Fengmei
    Xu, Lanping
    Zhang, Xiaohui
    Chang, Yingjun
    Mo, Xiaodong
    Sun, Yuqian
    Huang, Xiaojun
    Wang, Yu
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (07): : 456.e1 - 456.e11
  • [29] Erratum: Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
    N I Noguera
    E Ammatuna
    D Zangrilli
    S Lavorgna
    M Divona
    F Buccisano
    S Amadori
    C Mecucci
    B Falini
    F Lo-Coco
    Leukemia, 2007, 21 (5) : 1135 - 1135
  • [30] Prognostic Significance Of NPM1 mutations In The Absence Of FLT3-ITD in Older Patients With AML: A SWOG Report
    Ostronoff, Fabiana
    Othus, Megan
    Meshinchi, Soheil
    Godwin, John E.
    Kopecky, Kenneth J.
    List, Alan
    Oehler, Vivian G.
    Petersdorf, Stephen
    Pogosova-Agadjanyan, Era L.
    Radich, Jerald
    Willman, Cheryl L.
    Appelbaum, Frederick R.
    Stirewalt, Derek L.
    BLOOD, 2013, 122 (21)
12345